Category: biotech

.Though Alkeus Pharmaceuticals’ oral eye condition resource failed to dramatically lessen geographical atrophy (GA) lesion growth, the biotech is presenting “clinically relevant” outcomes as well

.While the biotech investment performance in Europe has slowed down rather complying with a COVID-19 funding boom in 2021, a new document from PitchBook recommends

.Merck &amp Co. has rapidly made back several of the expenses of its Harp on Rehabs acquistion, pulling in $170 thousand beforehand by incorporating the

.Cullinan Therapeutics was wowed sufficient along with Port BioMed’s bispecific immune reactor that it turned over $25 thousand last year for the medicine’s united state

.Invite to recently’s Chutes &amp Ladders, our summary of significant management hirings, firings and also retirings throughout the field. Please send out the good word–

.Compass Pathways’ experience to period 3 psychedelic depression data is taking longer than counted on. Along with the tests swamping through months, the biotech is

.Tip has actually disclosed period 3 records on its own near-approval ache drug applicant suzetrigine, shedding light on exactly how the non-opioid medicine mixes with

.Knowledge Rehabs’ stage 2 sparkle trial has taken a few of the luster off the Alzheimer’s disease drug candidate CT1812. The dental sigma-2 villain stopped

.Welcome to today’s Chutes &amp Ladders, our roundup of substantial leadership hirings, firings and also retirings throughout the market. Please deliver the good word– or

.Mandarin insulin creator Gan &amp Lee Pharmaceuticals is wading into the obesity planet with an injectable GLP-1 agonist that beat Novo Nordisk’s Ozempic (semaglutide) at